These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 17391569

  • 1. L-arginine plus atorvastatin for prevention of atheroma formation in genetically hypercholesterolaemic rabbits.
    Rasmusen C, Moinard C, Martin C, Tricottet V, Cynober L, Couderc R.
    Br J Nutr; 2007 Jun; 97(6):1083-9. PubMed ID: 17391569
    [Abstract] [Full Text] [Related]

  • 2. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
    Worthley SG, Helft G, Corti R, Worthley MI, Chew DP, Fayad ZA, Zaman AG, Fallon JT, Fuster V, Badimon JJ.
    Pathophysiol Haemost Thromb; 2007 Jun; 36(1):9-17. PubMed ID: 18332609
    [Abstract] [Full Text] [Related]

  • 3. The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine.
    Brinkmann SJ, Wörner EA, Buijs N, Richir M, Cynober L, van Leeuwen PA, Couderc R.
    Int J Mol Sci; 2015 May 29; 16(6):12230-42. PubMed ID: 26035753
    [Abstract] [Full Text] [Related]

  • 4. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
    Boodhwani M, Nakai Y, Voisine P, Feng J, Li J, Mieno S, Ramlawi B, Bianchi C, Laham R, Sellke FW.
    Circulation; 2006 Jul 04; 114(1 Suppl):I402-8. PubMed ID: 16820608
    [Abstract] [Full Text] [Related]

  • 5. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
    Tanaka N, Katayama Y, Katsumata T, Otori T, Nishiyama Y.
    Brain Res; 2007 Sep 12; 1169():125-32. PubMed ID: 17706949
    [Abstract] [Full Text] [Related]

  • 6. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.
    Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Kihara T, Tanaka N, Nakaya K, Ogura M, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Tamai S, Ohsuzu F.
    Eur J Cardiovasc Prev Rehabil; 2009 Apr 12; 16(2):222-8. PubMed ID: 19242355
    [Abstract] [Full Text] [Related]

  • 7. Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.
    Imanishi T, Ikejima H, Tsujioka H, Kuroi A, Kobayashi K, Shiomi M, Muragaki Y, Mochizuki S, Goto M, Yoshida K, Akasaka T.
    Hypertens Res; 2008 Jun 12; 31(6):1199-208. PubMed ID: 18716369
    [Abstract] [Full Text] [Related]

  • 8. [Arginine and statins: relationship between the nitric oxide pathway and the atherosclerosis development].
    Rasmusen C, Cynober L, Couderc R.
    Ann Biol Clin (Paris); 2005 Jun 12; 63(5):443-55. PubMed ID: 16230278
    [Abstract] [Full Text] [Related]

  • 9. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 12; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 10. Atorvastatin attenuates inflammatory infiltration and vascular remodeling in lung of hypercholesterolemia rabbits.
    Duan S, Zhang Y, Wu SJ, Jiang LZ, Zhang J, Gan Y, Chen P, Zhao SP, Li GY.
    Exp Lung Res; 2010 Dec 12; 36(10):573-92. PubMed ID: 21043990
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.
    Clin Ther; 2007 Nov 12; 29(11):2365-73. PubMed ID: 18158077
    [Abstract] [Full Text] [Related]

  • 12. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
    Konduracka E, Galicka-Latala D, Cieslik G, Rostoff P, Fedak D, Sieradzki J, Naskalski J, Piwowarska W.
    Diabetes Obes Metab; 2008 Sep 12; 10(9):719-25. PubMed ID: 17941871
    [Abstract] [Full Text] [Related]

  • 13. Randomised study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia.
    Jayaram S, Prasad HB, Sovani VB, Langade DG, Mane PR.
    J Indian Med Assoc; 2007 Mar 12; 105(3):142-5, 150. PubMed ID: 17824470
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Atorvastatin reduces serum leptin concentration in hypercholesterolemic rabbits.
    Zhao SP, Wu ZH.
    Clin Chim Acta; 2005 Oct 12; 360(1-2):133-40. PubMed ID: 16014304
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits.
    Nicholls SJ, Cutri B, Worthley SG, Kee P, Rye KA, Bao S, Barter PJ.
    Arterioscler Thromb Vasc Biol; 2005 Nov 12; 25(11):2416-21. PubMed ID: 16141405
    [Abstract] [Full Text] [Related]

  • 19. Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine.
    Bolayirli IM, Aslan M, Balci H, Altug T, Hacibekiroglu M, Seven A.
    Life Sci; 2007 Jun 20; 81(2):121-7. PubMed ID: 17532348
    [Abstract] [Full Text] [Related]

  • 20. Post-stroke atorvastatin treatment reduces neurological deficits and mortality rate in the stroke-prone spontaneously hypertensive rat.
    Hayashi A, Suzuki M, Ogawa Y, Sonoda R, Sasamata M.
    J Pharm Pharmacol; 2004 Jul 20; 56(7):893-8. PubMed ID: 15233868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.